Results 111 to 120 of about 57,948 (293)

Automated analysis of three-dimensional stress echocardiography [PDF]

, 2011
Real-time three-dimensional (3D) ultrasound imaging has been proposed as an alternative for two-dimensional stress echocardiography for assessing myocardial dysfunction and underlying coronary artery disease.
van der Steen, A.F.W., G. van Burken, M. van Stralen, Bosch, J.G., van Stralen, M.M., K. Y. E. Leung, Burken, G. van, de Jong, N., A. F. W. van der Steen, Stralen, M.M. van, Leung, K.Y.E. (Esther), Jong, N. (Nico) de, Burken, G. (Gerard) van, van Burken, G., Steen, A.F.W. (Ton) van der, van Stralen, M.M.; id_orcid, Danilouchkine, M.G., Stralen, M. (Marijn) van, N. de Jong, Steen, A.F.W. van der, Reiber, J.H.C., Danilouchkine, M.G. (Mikhail), J. H. C. Reiber, Leung, K.Y.E., Reiber, J.H.C. (Johan), M. L. Geleijnse, Jong, N. de, Geleijnse, M.L., J. G. Bosch, Geleijnse, M.L. (Marcel), Bosch, J.G. (Hans), Stralen, M. van, M. G. Danilouchkine   +32 more
core   +1 more source

CardiLect: A combined cross‐species lectin histochemistry protocol for the automated analysis of cardiac remodelling

ESC Heart Failure, Volume 12, Issue 2, Page 1398-1415, April 2025.
Abstract Background Cardiac remodelling, a crucial aspect of heart failure, is commonly investigated in preclinical models by quantifying cardiomyocyte cross‐sectional area (CSA) and microvascular density (MVD) via histological methods, such as immunohistochemistry.
Tamás G. Gergely, Tamás Kovács, Andrea Kovács, Viktória E. Tóth, Nabil V. Sayour, Gábor M. Mórotz, Csenger Kovácsházi, Gábor B. Brenner, Zsófia Onódi, Balázs Enyedi, Domokos Máthé, Przemyslaw Leszek, Zoltán Giricz, Péter Ferdinandy, Zoltán V. Varga   +14 more
wiley   +1 more source

Making three-dimensional echocardiography more tangible: a workflow for three-dimensional printing with echocardiographic data

Echo Research and Practice, 2016
Three-dimensional (3D) printing is a rapidly evolving technology with several potential applications in the diagnosis and management of cardiac disease. Recently, 3D printing (i.e. rapid prototyping) derived from 3D transesophageal echocardiography (TEE)
Azad Mashari MD, Mario Montealegre-Gallegos MD, Ziyad Knio BS, Lu Yeh MD, Jelliffe Jeganathan MBBS, Robina Matyal MD, Kamal R Khabbaz MD, Feroze Mahmood MD   +7 more
doaj   +1 more source

Real Time Three Dimensional Fetal Echocardiography Using Two Dimensional Array Technology [PDF]

, 2012
Three dimensional (3D) echocardiography represents a major paradigm shift in medical ultrasound imaging. As opposed to reconstructed 3D echocardiography which is based on a series of two dimensional images, the revolutionary development of the two ...
Timothy Bennett, David Mundy, Dev Maulik
core   +1 more source

Heart failure in two male patients with late‐onset Fabry mutation (IVS4 + 919G > A)

ESC Heart Failure, Volume 12, Issue 2, Page 1508-1513, April 2025.
Xufei Yang, Chunlan Deng, Xiaogang Guo, Hui Yan   +3 more
wiley   +1 more source

SPARCL1 and NT‐proBNP as biomarkers of right ventricular‐to‐pulmonary artery uncoupling in pulmonary hypertension

ESC Heart Failure, Volume 12, Issue 2, Page 1416-1426, April 2025.
Abstract Aims SPARCL1 was recently identified as a biomarker of right ventricular (RV) maladaptation in patients with pulmonary hypertension (PH), and N‐terminal pro‐brain natriuretic protein (NT‐proBNP) is an established biomarker of RV failure in PH. The present study investigated whether NT‐proBNP and SPARCL1 concentrations are associated with load ...
Oliver Dörr, Stanislav Keranov, Paulina van Wickern, Holger Nef, Christian Hamm, Pascal Bauer, Christian Troidl, Samuel Sossalla, Sandra Voss, Christoph Liebetrau, Manuel J. Richter, Henning Gall, Werner Seeger, Ardeschir Ghofrani, Athiththan Yogeswaran, Khodr Tello   +15 more
wiley   +1 more source

Three-dimensional echocardiographic analysis of electromechanical synchrony: comparison with three-dimensional and two-dimensional ejection fraction for evaluation of left ventricular systolic performance [PDF]

Einstein (São Paulo), 2008
Objective: To compare the three-dimensional echocardiographic analysisof left ventricular (LV) synchrony to LV ejection fraction (LVEF) as measuredby two-dimensional (2D) and three-dimensional (3D) echocardiography(ECHO).
Marcelo Luiz Campos Vieira, Alexandre Ferreira Cury, Gustavo Alberto Frazatto Naccarato, Wercules Antonio Alves de Oliveira, Adriana Cordovil, Ana Clara Tude Rodrigues, Claudia Gianini Monaco, Edgar Bezerra Lira Filho, Glaucia Maria Penha Tavares, Abraham Pfeferman, Marcia Regina Pinho Makdisse, Claudio Henrique Fischer, Samira Saady Morhy   +12 more
doaj  

Three-dimensional transesophageal echocardiography of the atrial septal defects [PDF]

, 2008
Transesophageal echocardiography has advantages over transthoracic technique in defining morphology of atrial structures. Even though real time three-dimensional echocardiographic imaging is a reality, the off-line reconstruction technique usually allows
Ángel Romero-Cárdenas, Erdmenger-Orellana Julio, Vázquez-Antona Clara, Luis Muñoz Castellanos, Romero-Cárdenas Ángel, Jesús Vargas-Barrón, Francisco-Javier Roldán, Clara Vázquez-Antona, Marco-Antonio Martínez-Ríos, Martínez-Ríos Marco-Antonio, Vargas-Barrón Jesús, Castellanos Luis, Roldán Francisco-Javier, Julio Erdmenger-Orellana   +13 more
core   +1 more source

Mortality risk stratification for Takotsubo syndrome: Evaluating CRP measurement alongside the InterTAK prognostic score

ESC Heart Failure, Volume 12, Issue 2, Page 1427-1436, April 2025.
Abstract Background and objectives Initially described as a benign acute cardiomyopathy, Takotsubo syndrome has been linked to elevated mortality rates. Emerging evidence suggests that unresolved myocardial inflammation may contribute to this adverse prognosis.
Loïc Faucher, Kensuke Matsushita, Shinnosuke Kikuchi, Taraneh Tatarcheh, Benjamin Marchandot, Amandine Granier, Said Amissi, Antonin Trimaille, Laurence Jesel, Patrick Ohlmann, Kiyoshi Hibi, Valérie Schini‐Kerth, Olivier Morel   +12 more
wiley   +1 more source

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

ESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad, Jeanne du Fay de Lavallaz, Michael J. Zhang, Thanat Chaikijurajai, Bo Ye, Prabhjot S. Nijjar, Julie A. Lahiri, Cindy M. Martin, Tamas Alexy, Markus Meyer   +9 more
wiley   +1 more source